Annemie Buelens

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

Oliver Lenz, Thierry Verbinnen, Bart Fevery et al. · Journal of Hepatology · 2014 · 132 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Clinical perspective on drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor rilpivirine.

Herta Crauwels, Rolf P. G. van Heeswijk, Marita Stevens et al. · PubMed · 2013 · 67 citations

Medicine, Pharmacokinetics, Pharmacology +17

Impact of Food and Different Meal Types on the Pharmacokinetics of Rilpivirine

Herta Crauwels, Rolf P. G. van Heeswijk, Annemie Buelens et al. · The Journal of Clinical Pharmacology · 2013 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers

Oliver Ackaert, Frédéric Vanhoutte, Nathalie Verpoorten et al. · Clinical Infectious Diseases · 2023 · 39 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

Mark Nelson, G. Amaya, Nathan Clumeck et al. · Journal of Antimicrobial Chemotherapy · 2012 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17